AnGes, Inc. (4563.T)
JPY 50.0
(2.04%)
JPY 50.0
(2.04%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -7.43 Billion JPY | 49.45% |
| 2022 | -14.71 Billion JPY | -7.6% |
| 2021 | -13.67 Billion JPY | -224.87% |
| 2020 | -4.2 Billion JPY | -12.23% |
| 2019 | -3.75 Billion JPY | -25.17% |
| 2018 | -2.99 Billion JPY | 20.4% |
| 2017 | -3.76 Billion JPY | 21.19% |
| 2016 | -4.77 Billion JPY | -15.29% |
| 2015 | -4.14 Billion JPY | -74.88% |
| 2014 | -2.36 Billion JPY | -68.07% |
| 2013 | -1.4 Billion JPY | 17.48% |
| 2012 | -1.7 Billion JPY | 5.88% |
| 2011 | -1.81 Billion JPY | 7.73% |
| 2010 | -1.96 Billion JPY | 32.66% |
| 2009 | -2.92 Billion JPY | 17.34% |
| 2008 | -3.53 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -1.82 Billion JPY | 30.89% |
| 2024 Q2 | -1.67 Billion JPY | 8.09% |
| 2023 Q1 | -2.91 Billion JPY | 35.58% |
| 2023 Q4 | -2.63 Billion JPY | -8397.85% |
| 2023 Q2 | -1.91 Billion JPY | 34.11% |
| 2023 FY | -7.43 Billion JPY | 49.45% |
| 2023 Q3 | 31.8 Million JPY | 101.66% |
| 2022 Q2 | -4.48 Billion JPY | -52.73% |
| 2022 Q4 | -4.51 Billion JPY | -63.24% |
| 2022 Q1 | -2.93 Billion JPY | -70.56% |
| 2022 FY | -14.71 Billion JPY | -7.6% |
| 2022 Q3 | -2.76 Billion JPY | 38.3% |
| 2021 Q2 | -4.13 Billion JPY | -24.79% |
| 2021 Q4 | -1.72 Billion JPY | 61.74% |
| 2021 FY | -13.67 Billion JPY | -224.87% |
| 2021 Q3 | -4.5 Billion JPY | -8.88% |
| 2021 Q1 | -3.31 Billion JPY | -220.28% |
| 2020 Q4 | -1.03 Billion JPY | 19.08% |
| 2020 Q2 | -976.03 Million JPY | -6.09% |
| 2020 Q1 | -919.96 Million JPY | 6.14% |
| 2020 Q3 | -1.27 Billion JPY | -31.01% |
| 2020 FY | -4.2 Billion JPY | -12.23% |
| 2019 Q1 | -1.18 Billion JPY | -49.12% |
| 2019 FY | -3.75 Billion JPY | -25.17% |
| 2019 Q3 | -796.9 Million JPY | -0.88% |
| 2019 Q2 | -789.92 Million JPY | 33.28% |
| 2019 Q4 | -980.1 Million JPY | -22.99% |
| 2018 Q2 | -610.1 Million JPY | -13.57% |
| 2018 Q1 | -537.19 Million JPY | -32.54% |
| 2018 Q3 | -1.05 Billion JPY | -73.0% |
| 2018 FY | -2.99 Billion JPY | 20.4% |
| 2018 Q4 | -793.88 Million JPY | 24.78% |
| 2017 Q2 | -787.94 Million JPY | 47.88% |
| 2017 FY | -3.76 Billion JPY | 21.19% |
| 2017 Q4 | -405.29 Million JPY | 61.75% |
| 2017 Q3 | -1.05 Billion JPY | -34.48% |
| 2017 Q1 | -1.51 Billion JPY | -58.68% |
| 2016 Q4 | -952.8 Million JPY | 4.58% |
| 2016 Q3 | -998.52 Million JPY | 37.41% |
| 2016 Q2 | -1.59 Billion JPY | -29.69% |
| 2016 Q1 | -1.23 Billion JPY | -8.33% |
| 2016 FY | -4.77 Billion JPY | -15.29% |
| 2015 Q2 | -1.15 Billion JPY | -30.78% |
| 2015 FY | -4.14 Billion JPY | -74.88% |
| 2015 Q1 | -883.99 Million JPY | -217.33% |
| 2015 Q3 | -967.68 Million JPY | 16.3% |
| 2015 Q4 | -1.13 Billion JPY | -17.35% |
| 2014 Q1 | -438.99 Million JPY | -0.25% |
| 2014 FY | -2.36 Billion JPY | -68.07% |
| 2014 Q2 | -529.85 Million JPY | -20.7% |
| 2014 Q4 | -278.57 Million JPY | 75.17% |
| 2014 Q3 | -1.12 Billion JPY | -111.71% |
| 2013 Q4 | -437.89 Million JPY | -37.11% |
| 2013 FY | -1.4 Billion JPY | 17.48% |
| 2013 Q3 | -319.38 Million JPY | -11.76% |
| 2013 Q2 | -285.78 Million JPY | 22.05% |
| 2013 Q1 | -366.63 Million JPY | 20.55% |
| 2012 Q2 | -441.54 Million JPY | 2.41% |
| 2012 Q4 | -461.46 Million JPY | -30.75% |
| 2012 Q3 | -352.92 Million JPY | 20.07% |
| 2012 FY | -1.7 Billion JPY | 5.88% |
| 2012 Q1 | -452.43 Million JPY | 26.69% |
| 2011 Q4 | -617.14 Million JPY | -58.07% |
| 2011 Q1 | -373.89 Million JPY | 40.15% |
| 2011 Q2 | -433.6 Million JPY | -15.97% |
| 2011 Q3 | -390.41 Million JPY | 9.96% |
| 2011 FY | -1.81 Billion JPY | 7.73% |
| 2010 Q1 | -444.26 Million JPY | 16.33% |
| 2010 Q2 | -431.47 Million JPY | 2.88% |
| 2010 Q4 | -624.71 Million JPY | -33.84% |
| 2010 Q3 | -466.77 Million JPY | -8.18% |
| 2010 FY | -1.96 Billion JPY | 32.66% |
| 2009 Q3 | -662.95 Million JPY | 39.05% |
| 2009 FY | -2.92 Billion JPY | 17.34% |
| 2009 Q2 | -1.08 Billion JPY | -70.02% |
| 2009 Q4 | -530.94 Million JPY | 19.91% |
| 2009 Q1 | -639.76 Million JPY | 0.0% |
| 2008 FY | -3.53 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 2036.877% |
| PRISM BioLab Co.,LTD | -526.91 Million JPY | -1311.541% |
| GNI Group Ltd. | 8.09 Billion JPY | 191.888% |
| Linical Co., Ltd. | 338.26 Million JPY | 2298.745% |
| Trans Genic Inc. | 4.08 Million JPY | 182171.163% |
| MEDINET Co., Ltd. | -1.43 Billion JPY | -417.237% |
| Soiken Holdings Inc. | -662.2 Million JPY | -1023.161% |
| Cytori Cell Research Institute, Inc. | 138.15 Million JPY | 5483.524% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | -477.392% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | -3.401% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | 4083.849% |
| NanoCarrier Co., Ltd. | -780 Million JPY | -853.537% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | -545.124% |
| CanBas Co., Ltd. | -1.2 Billion JPY | -515.187% |
| D. Western Therapeutics Institute, Inc. | -812.41 Million JPY | -815.498% |
| RaQualia Pharma Inc. | -323.66 Million JPY | -2197.955% |
| Chiome Bioscience Inc. | -1.22 Billion JPY | -509.631% |
| Kidswell Bio Corporation | -1.42 Billion JPY | -423.01% |
| PeptiDream Inc. | 3.03 Billion JPY | 344.994% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | -283.677% |
| Ribomic Inc. | -1.02 Billion JPY | -626.161% |
| SanBio Company Limited | -2.64 Billion JPY | -181.301% |
| Healios K.K. | -3.82 Billion JPY | -94.549% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | -536.737% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.48 Billion JPY | -399.302% |
| Delta-Fly Pharma, Inc. | -1.42 Billion JPY | -420.333% |
| StemRIM | -2.02 Billion JPY | -267.834% |
| CellSource Co., Ltd. | 923.14 Million JPY | 905.684% |
| FunPep Company Limited | -933.41 Million JPY | -696.816% |
| Kringle Pharma, Inc. | -854.15 Million JPY | -770.76% |
| Stella Pharma Corporation | -763.74 Million JPY | -873.829% |
| TMS Co., Ltd. | -960.04 Million JPY | -674.718% |
| Noile-Immune Biotech Inc. | -1.13 Billion JPY | -558.187% |
| Cuorips Inc. | -632.18 Million JPY | -1076.496% |
| K Pharma,Inc. | 260.33 Million JPY | 2956.992% |
| Takara Bio Inc. | 1.48 Billion JPY | 602.541% |
| ReproCELL Incorporated | -31.41 Million JPY | -23575.337% |
| PhoenixBio Co., Ltd. | 26.37 Million JPY | 28296.251% |
| StemCell Institute Inc. | 310.98 Million JPY | 2491.66% |
| Japan Tissue Engineering Co., Ltd. | 143.16 Million JPY | 5294.984% |
| CellSeed Inc. | -846.53 Million JPY | -778.595% |